Dragan Golijanin, MD, is director of genitourinary oncology at Rhode Island and The Miriam Hospitals and assistant professor of surgery (urology) at the Warren Alpert Medical School of Brown University. Golijanin completed his medical school at University of Belgrade in 1984. He completed his urology residency at the University of Belgrade and Hadassah University Hospital in Jerusalem, Hebrew University. This was followed by fellowship training in genitourinary oncology and molecular biology research at Memorial Sloan-Kettering Cancer Center and Cornell University, Weill Medical School in New York. He joined the University of Rochester in 2003. Golijanin acquired his board certification in urology by the American Board of Urology in 2011. Since 2009 he worked as an attending and genitourinary oncologist at Strong Memorial Hospital of University of Rochester, NY.
Golijanin has received several awards including the Donsky Foundation Award in Jerusalem, Israel in 1995 as well as the Murphy Scholar award in 2007. He is listed as one of the Best Doctors in America. He is a reviewer for several urology journals, including Urology and Journal of Urology and is and editor for Frontiers in genitourinary oncology.
His clinical and research focus is the treatment of patients with cancers of prostate, bladder, kidney and testis. He has published over 55 articles in peer-reviewed journals since 1995 on issues related to prostate, bladder, kidney and testis cancer. His current research focus is on the development of imaging modalities using near infrared fluorescence as well as targeted imaging using different coupled antibodies and coupled specific inhibitors of different tumor and normal cells. These imaging modalities were developed in last eight years, pioneering work in imaging of prostate and renal cell carcinomas as well as bladder cancer, imaging of lymph nodes and tumors real time, intraoperatively assessing tumor location and spread. He was the first to publish on near infrared imaging in open, laparoscopic and robotic surgery real time.
Golijanin continues his research with Thomas Webster, PhD, of Brown University and his colleagues from the divisions of urology, pathology and oncology. He also continues with work on outcome analyses in bladder and renal cancer. Clinically, Golijanin is co-director with Anthony Mega, MD, of the Genitourinary Multidisciplinary Clinic (GUMDC) at The Miriam Hospital. Golijanin performs robotic laparoscopic and endoscopic surgery at The Miriam Hospital and open oncological procedures at Rhode Island Hospital.